Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

611
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

44
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
44
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

20
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
20
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

544
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
544

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Creation of a Merged Harmonized Large Database of Subject-Level Data from Acute Secondary Prevention Studies in Minor Non-Cardioembolic Stroke or TIA.

International journal of cerebrovascular disease and stroke·2026
Same author

Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis.

JAMA network open·2026
Same author

Cost Effectiveness of Endovascular Thrombectomy for Large Ischemic Strokes: A US Healthcare Payer Markov Model Informed by Randomized Trials.

Applied health economics and health policy·2026
Same author

Mechanical circulatory assist devices stroke subtype classification: a novel stroke classification system in patients with ventricular assist devices.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same author

Understanding the Relationship Between Cerebrovascular Disease and the Gut Microbiome.

Stroke (Hoboken, N.J.)·2026
Same author

Cervical Internal Carotid Artery Plaque Composition and Chronic White Matter Disease in Patients with Noncardioembolic Stroke: A Multicenter Analysis.

Stroke (Hoboken, N.J.)·2026
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

495

Risk factor management for stroke prevention.

Shyam Prabhakaran, Ji Y Chong

    Continuum (Minneapolis, Minn.)
    |April 5, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Effective secondary stroke prevention involves managing hypertension, dyslipidemia, and diabetes. Lifestyle changes and addressing novel risk factors like sleep apnea can significantly reduce recurrent stroke risk.

    More Related Videos

    A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
    04:38

    A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

    Published on: May 22, 2019

    9.4K
    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
    09:21

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

    Published on: January 18, 2018

    14.4K

    Related Experiment Videos

    Last Updated: May 1, 2026

    The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
    06:38

    The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

    Published on: December 19, 2025

    495
    A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
    04:38

    A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

    Published on: May 22, 2019

    9.4K
    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
    09:21

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

    Published on: January 18, 2018

    14.4K

    Area of Science:

    • Neurology
    • Cardiovascular Medicine
    • Preventive Medicine

    Background:

    • Neurologic practice frequently involves managing patients with hypertension, dyslipidemia, and diabetes mellitus.
    • Lifestyle factors such as diet and physical activity are critical in managing these conditions.
    • Secondary stroke prevention is paramount to reduce morbidity and mortality.

    Purpose of the Study:

    • To review current recommendations for managing common risk factors in neurologic practice.
    • To highlight the impact of pharmacologic strategies and lifestyle modifications on recurrent stroke.
    • To discuss both traditional and novel modifiable risk factors for stroke.

    Main Methods:

    • Systematic review of recent studies on hypertension, dyslipidemia, and diabetes management.
    • Analysis of research on lipid targets, blood pressure targets, and medication adherence post-stroke.
    • Inclusion of studies on diet, physical activity, sleep apnea, and other lifestyle factors.

    Main Results:

    • Aggressive pharmacologic strategies for lipid and blood pressure lowering significantly impact recurrent stroke risk.
    • Modifiable risk factors, including hypertension, dyslipidemia, diabetes, sleep apnea, diet, and physical activity, are discussed.
    • Evidence supports the efficacy of targeting specific lipid and blood pressure levels to prevent stroke recurrence.

    Conclusions:

    • Optimal secondary prevention strategies can prevent up to 80% of all recurrent strokes.
    • Comprehensive management of traditional and novel risk factors is essential for stroke prevention.
    • Adherence to medication and lifestyle modifications are key components of secondary stroke prevention.